edoc-vmtest

Oral treatment for Mycobacterium ulcerans infection : results from a pilot study in Benin

Chauty, A. and Ardant, M. F. and Marsollier, L. and Pluschke, G. and Landier, J. and Adeye, A. and Goundoté, A. and Cottin, J. and Ladikpo, T. and Ruf, T. and Ji, B.. (2011) Oral treatment for Mycobacterium ulcerans infection : results from a pilot study in Benin. Clinical Infectious Diseases, Vol. 52, H. 1. pp. 94-96.

[img] PDF - Published Version
77Kb

Official URL: http://edoc.unibas.ch/dok/A6002292

Downloads: Statistics Overview

Abstract

Mycobacterium ulcerans infection is responsible for severe skin lesions in sub-Saharan Africa. We enrolled 30 Beninese patients with Buruli ulcers in a pilot study to evaluate efficacy of an oral chemotherapy using rifampicin plus clarithromycin during an 8-week period. The treatment was well tolerated, and all patients were healed by 12 months after initiation of therapy without relapse
Faculties and Departments:09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Medical Parasitology and Infection Biology (MPI) > Molecular Immunology (Pluschke)
UniBasel Contributors:Pluschke, Gerd
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Oxford University Press
ISSN:1058-4838
Note:Publication type according to Uni Basel Research Database: Journal article
Language:English
Related URLs:
Identification Number:
edoc DOI:
Last Modified:13 Mar 2018 17:17
Deposited On:08 Nov 2012 16:13

Repository Staff Only: item control page